{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:07:09Z","timestamp":1787065629160,"version":"build-2736575974"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10555-017-9661-5","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T02:52:41Z","timestamp":1489114361000},"page":"77-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Identification, genetic testing, and management of hereditary melanoma"],"prefix":"10.1007","volume":"36","author":[{"given":"Sancy A.","family":"Leachman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jone E.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Queirolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ghiorzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"issue":"3","key":"9661_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jaad.2015.09.070","volume":"74","author":"KJ Ransohoff","year":"2016","unstructured":"Ransohoff, K. J., Jaju, P. D., Tang, J. Y., Carbone, M., Leachman, S., & Sarin, K. Y. (2016). Familial skin cancer syndromes increased melanoma risk. Journal of the American Academy of Dermatology, 74(3), 423\u2013434. doi: 10.1016\/j.jaad.2015.09.070 .","journal-title":"Journal of the American Academy of Dermatology"},{"key":"9661_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","volume":"53","author":"J Read","year":"2015","unstructured":"Read, J., Wadt, K. A. W., & Hayward, N. K. (2015). Melanoma genetics. Journal of Medical Genetics, 53, 1\u201314. doi: 10.1136\/jmedgenet-2015-103150 .","journal-title":"Journal of Medical Genetics"},{"issue":"2","key":"9661_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jmg.2006.043802","volume":"44","author":"AM Goldstein","year":"2007","unstructured":"Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Bishop, D. T., et al. (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. Journal of Medical Genetics, 44(2), 99\u2013106. doi: 10.1136\/jmg.2006.043802 .","journal-title":"Journal of Medical Genetics"},{"issue":"5","key":"9661_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s10865-015-9648-z","volume":"38","author":"JM Taber","year":"2015","unstructured":"Taber, J. M., Aspinwall, L. G., Stump, T. K., Kohlmann, W., Champine, M., & Leachman, S. A. (2015). Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone. Journal of Behavioral Medicine, 38(5), 740\u2013753. doi: 10.1007\/s10865-015-9648-z .","journal-title":"Journal of Behavioral Medicine"},{"key":"9661_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12671-013-0269-8.Moving","volume":"16","author":"LG Aspinwall","year":"2014","unstructured":"Aspinwall, L. G., Taber, J. M., Kohlmann, W., Leaf, S. L., & Leachman, S. A. (2014). Unaffected family members report improvements in daily routine sun-protection 2\u00a0years following melanoma genetic testing. Genetics in Medicine, 16, 356\u2013372. doi: 10.1007\/s12671-013-0269-8.Moving .","journal-title":"Genetics in Medicine"},{"issue":"20","key":"9661_CR6","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","volume":"66","author":"AM Goldstein","year":"2006","unstructured":"Goldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M. F., et al. (2006). High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Research, 66(20), 9818\u20139828. doi: 10.1158\/0008-5472.CAN-06-0494 .","journal-title":"Cancer Research"},{"issue":"3","key":"9661_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/sj.jid.5700094","volume":"126","author":"MJ Eliason","year":"2006","unstructured":"Eliason, M. J., Larson, A. A., Florell, S. R., Zone, J. J., Cannon-Albright, L. A., Samlowski, W. E., & Leachman, S. A. (2006). Population-based prevalence of CDKN2A mutations in Utah melanoma families. The Journal of Investigative Dermatology, 126(3), 660\u2013666. doi: 10.1038\/sj.jid.5700094 .","journal-title":"The Journal of Investigative Dermatology"},{"key":"9661_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., et al. (1994). Germline p16 mutations in familial melanoma. Nature Genetics, 8, 15\u201321. doi: 10.1038\/ng0994-15 .","journal-title":"Nature Genetics"},{"issue":"1","key":"9661_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., et al. (1994). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genetics, 8(1), 22\u201326. doi: 10.1038\/ng0994-22 .","journal-title":"Nature Genetics"},{"issue":"6","key":"9661_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","volume":"92","author":"Y Zhang","year":"1998","unstructured":"Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92(6), 725\u2013734. doi: 10.1016\/S0092-8674(00)81401-4 .","journal-title":"Cell"},{"issue":"September 2003","key":"9661_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/humu.9247","volume":"23","author":"AM Goldstein","year":"2004","unstructured":"Goldstein, A. M. (2004). Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Human Mutation, 23(September 2003), 630. doi: 10.1002\/humu.9247 .","journal-title":"Human Mutation"},{"issue":"6","key":"9661_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","volume":"87","author":"HFA Vasen","year":"2000","unstructured":"Vasen, H. F. A., Gruis, N. A., Frants, R. R., Van Der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000). Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). International Journal of Cancer, 87(6), 809\u2013811. doi: 10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U .","journal-title":"International Journal of Cancer"},{"issue":"3","key":"9661_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10689-016-9888-2","volume":"15","author":"HT Lynch","year":"2016","unstructured":"Lynch, H. T., & Shaw, T. G. (2016). Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity. Familial Cancer, 15(3), 487\u2013491. doi: 10.1007\/s10689-016-9888-2 .","journal-title":"Familial Cancer"},{"issue":"11","key":"9661_CR14","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00439-016-1715-1","volume":"135","author":"XR Yang","year":"2016","unstructured":"Yang, X. R., Rotunno, M., Xiao, Y., Ingvar, C., Helgadottir, H., Pastorino, L., et al. (2016). Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations. Human Genetics, 135(11), 1241\u20131249. doi: 10.1007\/s00439-016-1715-1 .","journal-title":"Human Genetics"},{"issue":"3","key":"9661_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaad.2015.08.038","volume":"74","author":"E Soura","year":"2016","unstructured":"Soura, E., Eliades, P. J., Shannon, K., Stratigos, A. J., & Tsao, H. (2016). Hereditary melanoma: update on syndromes and management genetics of familial atypical multiple mole melanoma syndrome. Journal of the American Academy of Dermatology, 74(3), 411\u2013420. doi: 10.1016\/j.jaad.2015.08.038 .","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"15","key":"9661_CR16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","volume":"92","author":"A Borg","year":"2000","unstructured":"Borg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., M\u00e5sb\u00e4ck, A., et al. (2000). High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. Journal of the National Cancer Institute, 92(15), 1260\u20131266.","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"9661_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/jmedgenet-2011-100281","volume":"49","author":"P Ghiorzo","year":"2012","unstructured":"Ghiorzo, P., Fornarini, G., Sciallero, S., Battistuzzi, L., Belli, F., Bernard, L., et al. (2012). CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. Journal of Medical Genetics, 49(3), 164\u2013170. doi: 10.1136\/jmedgenet-2011-100281 .","journal-title":"Journal of Medical Genetics"},{"issue":"31","key":"9661_CR18","doi-asserted-by":"publisher","first-page":"10778","DOI":"10.3748\/wjg.v20.i31.10778","volume":"20","author":"P Ghiorzo","year":"2014","unstructured":"Ghiorzo, P. (2014). Genetic predisposition to pancreatic cancer. World Journal of Gastroenterology, 20(31), 10778. doi: 10.3748\/wjg.v20.i31.10778 .","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"9661_CR19","doi-asserted-by":"publisher","first-page":"677.e1","DOI":"10.1016\/j.jaad.2009.03.016","volume":"61","author":"SA Leachman","year":"2009","unstructured":"Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., et al. (2009). Selection criteria for genetic assessment of patients with familial melanoma. Journal of the American Academy of Dermatology, 61(4), 677.e1\u2013677.14. doi: 10.1016\/j.jaad.2009.03.016 .","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"9661_CR20","first-page":"2298","volume":"58","author":"M Bahuau","year":"1998","unstructured":"Bahuau, M., Vidaud, D., Jenkins, R. B., Bi\u00e8che, I., Kimmel, D. W., Assouline, B., et al. (1998). Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Research, 58(11), 2298\u20132303.","journal-title":"Cancer Research"},{"key":"9661_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng0196-97","volume":"12","author":"L Zuo","year":"1996","unstructured":"Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., et al. (1996). Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nature Genetics, 12, 97\u201399. doi: 10.1038\/ng0196-97 .","journal-title":"Nature Genetics"},{"key":"9661_CR22","doi-asserted-by":"publisher","unstructured":"Soufir, N. (1998). Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]. Human Molecular Genetics, 7(2), 209\u2013216. doi: 10.1093\/hmg\/7.2.209","DOI":"10.1093\/hmg\/7.2.209"},{"issue":"4","key":"9661_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2012-101455","volume":"50","author":"HE Puntervoll","year":"2013","unstructured":"Puntervoll, H. E., Yang, X. R., Vetti, H. H., Bachmann, I. M., Avril, M. F., Benfodda, M., et al. (2013). Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. Journal of Medical Genetics, 50(4), 264\u2013270. doi: 10.1136\/jmedgenet-2012-101455 .","journal-title":"Journal of Medical Genetics"},{"issue":"6122","key":"9661_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., et al. (2013). TERT promoter mutations in familial and sporadic melanoma. Science, 339(6122), 959\u2013961. doi: 10.1126\/science.1230062 .","journal-title":"Science"},{"issue":"6122","key":"9661_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013). Highly recurrent TERT promoter mutations in human melanoma. Science, 339(6122), 957\u2013959. doi: 10.1126\/science.1229259 .","journal-title":"Science"},{"issue":"5","key":"9661_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng.2941","volume":"46","author":"J Shi","year":"2014","unstructured":"Shi, J., Yang, X. R., Ballew, B., Rotunno, M., Calista, D., Fargnoli, M. C., et al. (2014). Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nature Genetics, 46(5), 482\u2013486. doi: 10.1038\/ng.2941 .","journal-title":"Nature Genetics"},{"issue":"5","key":"9661_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ng.2947","volume":"46","author":"CD Robles-Espinoza","year":"2014","unstructured":"Robles-Espinoza, C. D., Harland, M., Ramsay, A. J., Aoude, L. G., Quesada, V., Ding, Z., et al. (2014). POT1 loss-of-function variants predispose to familial melanoma. Nature Genetics, 46(5), 478\u2013481. doi: 10.1038\/ng.2947 .","journal-title":"Nature Genetics"},{"issue":"2","key":"9661_CR28","doi-asserted-by":"publisher","first-page":"dju408","DOI":"10.1093\/jnci\/dju408","volume":"107","author":"LG Aoude","year":"2014","unstructured":"Aoude, L. G., Pritchard, A. L., Robles-Espinoza, C. D., Wadt, K., Harland, M., Choi, J., et al. (2014). Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. JNCI Journal of the National Cancer Institute, 107(2), dju408. doi: 10.1093\/jnci\/dju408 .","journal-title":"JNCI Journal of the National Cancer Institute"},{"issue":"6009","key":"9661_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., et al. (2010). Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (New York, N.Y.), 330(6009), 1410\u20131413. doi: 10.1126\/science.1194472 .","journal-title":"Science (New York, N.Y.)"},{"issue":"10","key":"9661_CR30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner, T., Obenauf, A. C., Murali, R., Fried, I., Griewank, K. G., Ulz, P., et al. (2011). Germline mutations in BAP1 predispose to melanocytic tumors. Nature Genetics, 43(10), 1018\u20131021. doi: 10.1038\/ng.910 .","journal-title":"Nature Genetics"},{"issue":"10","key":"9661_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa, J. R., Cheung, M., Pei, J., Below, J. E., Tan, Y., Sementino, E., et al. (2011). Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics, 43(10), 1022\u20131025. doi: 10.1038\/ng.912 .","journal-title":"Nature Genetics"},{"issue":"12","key":"9661_CR32","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman, M. H., Pilarski, R., Cebulla, C. M., Massengill, J. B., Christopher, B. N., Boru, G., et al. (2011). Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. Journal of Medical Genetics, 48(12), 856\u2013859. doi: 10.1136\/jmedgenet-2011-100156 .","journal-title":"Journal of Medical Genetics"},{"issue":"9","key":"9661_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jclinpath-2016-203866","volume":"69","author":"A Wang","year":"2016","unstructured":"Wang, A., Papneja, A., Hyrcza, M., Al-Habeeb, A., & Ghazarian, D. (2016). Gene of the month: BAP1. Journal of Clinical Pathology, 69(9), 750\u2013753. doi: 10.1136\/jclinpath-2016-203866 .","journal-title":"Journal of Clinical Pathology"},{"issue":"3","key":"9661_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cge.12630","volume":"89","author":"K Rai","year":"2016","unstructured":"Rai, K., Pilarski, R., Cebulla, C. M., & Abdel-Rahman, M. H. (2016). Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clinical Genetics, 89(3), 285\u2013294. doi: 10.1111\/cge.12630 .","journal-title":"Clinical Genetics"},{"issue":"7375","key":"9661_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature10539","volume":"480","author":"C Bertolotto","year":"2011","unstructured":"Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., et al. (2011). A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature, 480(7375), 94\u201398. doi: 10.1038\/nature10539 .","journal-title":"Nature"},{"issue":"7375","key":"9661_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature10630","volume":"480","author":"S Yokoyama","year":"2011","unstructured":"Yokoyama, S., Woods, S. L., Boyle, G. M., Aoude, L. G., MacGregor, S., Zismann, V., et al. (2011). A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature, 480(7375), 99\u2013103. doi: 10.1038\/nature10630 .","journal-title":"Nature"},{"issue":"2","key":"9661_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/pcmr.12047","volume":"26","author":"P Ghiorzo","year":"2013","unstructured":"Ghiorzo, P., Pastorino, L., Queirolo, P., Bruno, W., Tibiletti, M. G., Nasti, S., et al. (2013). Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell & Melanoma Research, 26(2), 259\u2013262. doi: 10.1111\/pcmr.12047 .","journal-title":"Pigment Cell & Melanoma Research"},{"issue":"5","key":"9661_CR38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/bjd.14897","volume":"175","author":"C Mangas","year":"2016","unstructured":"Mangas, C., Potrony, M., Mainetti, C., Bianchi, E., Carrozza Merlani, P., Mancarella Eberhardt, A., et al. (2016). Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF. British Journal of Dermatology, 175(5), 1030\u20131037. doi: 10.1111\/bjd.14897 .","journal-title":"British Journal of Dermatology"},{"key":"9661_CR39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2103","author":"LJ Castro-Vega","year":"2016","unstructured":"Castro-Vega, L. J., Kiando, S. R., Burnichon, N., Buffet, A., Amar, L., Simian, C., et al. (2016). The MITF, p.E318K variant as a risk factor for pheochromocytoma and paraganglioma. The Journal of Clinical Endocrinology & Metabolism. doi: 10.1210\/jc.2016-2103 .","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"9661_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/gcc.20202","volume":"44","author":"A Molven","year":"2005","unstructured":"Molven, A., Grimstvedt, M. B., Steine, S. J., Harland, M., Avril, M.-F., Hayward, N. K., & Akslen, L. A. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, andCDK4 mutation. Genes, Chromosomes and Cancer, 44(1), 10\u201318. doi: 10.1002\/gcc.20202 .","journal-title":"Genes, Chromosomes and Cancer"},{"issue":"8","key":"9661_CR41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1568-7864(02)00052-6","volume":"1","author":"J Tang","year":"2002","unstructured":"Tang, J., & Chu, G. (2002). Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein. DNA Repair, 1(8), 601\u2013616.","journal-title":"DNA Repair"},{"issue":"2","key":"9661_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","volume":"18","author":"M-H Tan","year":"2012","unstructured":"Tan, M.-H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012). Lifetime cancer risks in individuals with germline PTEN mutations. Clinical Cancer Research, 18(2), 400\u2013407. doi: 10.1158\/1078-0432.CCR-11-2283 .","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"9661_CR43","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s00432-002-0360-3","volume":"128","author":"C P\u00f6tzsch","year":"2002","unstructured":"P\u00f6tzsch, C., Voigtl\u00e4nder, T., & L\u00fcbbert, M. (2002). p53 germline mutation in a patient with Li-Fraumeni syndrome and three metachronous malignancies. Journal of Cancer Research and Clinical Oncology, 128(8), 456\u2013460. doi: 10.1007\/s00432-002-0360-3 .","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"5","key":"9661_CR44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaad.2009.03.039","volume":"61","author":"W Bruno","year":"2009","unstructured":"Bruno, W., Ghiorzo, P., Battistuzzi, L., Ascierto, P. A., Barile, M., Gargiulo, S., et al. (2009). Clinical genetic testing for familial melanoma in Italy: a cooperative study. Journal of the American Academy of Dermatology, 61(5), 775\u2013782. doi: 10.1016\/j.jaad.2009.03.039 .","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"9661_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jaad.2015.09.053","volume":"74","author":"W Bruno","year":"2016","unstructured":"Bruno, W., Pastorino, L., Ghiorzo, P., Andreotti, V., Martinuzzi, C., Menin, C., et al. (2016). Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup. Journal of the American Academy of Dermatology, 74(2), 325\u2013332. doi: 10.1016\/j.jaad.2015.09.053 .","journal-title":"Journal of the American Academy of Dermatology"},{"key":"9661_CR46","unstructured":"Cancer of the Breast (Female) - SEER Stat Fact Sheets. (n.d.). Retrieved from https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html ."},{"key":"9661_CR47","series-title":"GeneReviews(\u00ae)","volume-title":"Xeroderma pigmentosum","author":"KH Kraemer","year":"1993","unstructured":"Kraemer, K. H., & DiGiovanna, J. J. (1993). Xeroderma pigmentosum, GeneReviews(\u00ae). Seattle: University of Washington."},{"issue":"3","key":"9661_CR48","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10689-012-9534-6","volume":"11","author":"M Pande","year":"2012","unstructured":"Pande, M., Wei, C., Chen, J., Amos, C. I., Lynch, P. M., Lu, K. H., et al. (2012). Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Familial Cancer, 11(3), 441\u2013447. doi: 10.1007\/s10689-012-9534-6 .","journal-title":"Familial Cancer"},{"key":"9661_CR49","unstructured":"Eng, C. (1993). PTEN hamartoma tumor syndrome. 2001 Nov 29 [Updated 2016 Jun 2]. In: PagonRA, Adam MP, Ardinger HH, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1488\/"},{"key":"9661_CR50","unstructured":"Genomic Medicine Institute - PTEN Cleveland Clinic Score Calculator for Estimation of PTEN Mutation Probability (n.d.). Retrieved January 4, 2017, from https:\/\/www.lerner.ccf.org\/gmi\/ccscore\/documents\/adult_criteria.php ."},{"issue":"1","key":"9661_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","volume":"88","author":"M-H Tan","year":"2011","unstructured":"Tan, M.-H., Mester, J., Peterson, C., Yang, Y., Chen, J.-L., Rybicki, L. A., et al. (2011). A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. American Journal of Human Genetics, 88(1), 42\u201356. doi: 10.1016\/j.ajhg.2010.11.013 .","journal-title":"American Journal of Human Genetics"},{"key":"9661_CR52","series-title":"GeneReviews(\u00ae)","volume-title":"Li-Fraumeni syndrome","author":"K Schneider","year":"1993","unstructured":"Schneider, K., Zelley, K., Nichols, K. E., & Garber, J. (1993). Li-Fraumeni syndrome, GeneReviews(\u00ae). Seattle: University of Washington."},{"key":"9661_CR53","unstructured":"Pilarski, R., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Dana-Farber, M., \u2026 Dwyer, M. (n.d.). NCCN guidelines version 1.2017 panel members genetic\/familial high-risk assessment: breast and ovarian DVM \u00a5 FORCE: facing our risk of cancer empowered."},{"issue":"3","key":"9661_CR54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.eururo.2014.01.003","volume":"66","author":"EK Bancroft","year":"2014","unstructured":"Bancroft, E. K., Page, E. C., Castro, E., Lilja, H., Vickers, A., Sjoberg, D., et al. (2014). Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. European Urology, 66(3), 489\u2013499. doi: 10.1016\/j.eururo.2014.01.003 .","journal-title":"European Urology"},{"issue":"5","key":"9661_CR55","doi-asserted-by":"crossref","first-page":"509","DOI":"10.6004\/jnccn.2016.0060","volume":"14","author":"PR Carroll","year":"2016","unstructured":"Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Castle, E. P., Catalona, W. J., et al. (2016). NCCN guidelines insights: prostate cancer early detection, version 2.2016. Journal of the National Comprehensive Cancer Network : JNCCN, 14(5), 509\u2013519.","journal-title":"Journal of the National Comprehensive Cancer Network : JNCCN"},{"key":"9661_CR56","unstructured":"Susan Darlow, N., Dwyer, M., Gupta, S., Ahnen, D. J., Bray, T., Cooper, G., \u2026 Weinberg, D. (n.d.). NCCN guidelines version 2.2016 panel members colorectal cancer screening."},{"key":"9661_CR57","series-title":"GeneReviews(\u00ae)","volume-title":"APC-associated polyposis conditions","author":"KW Jasperson","year":"1993","unstructured":"Jasperson, K. W., & Burt, R. W. (1993). APC-associated polyposis conditions, GeneReviews(\u00ae). Seattle: University of Washington."},{"issue":"3","key":"9661_CR58","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","volume":"62","author":"MI Canto","year":"2013","unstructured":"Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., et al. (2013). International Cancer of the Pancreas Screening (CAPS) consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut, 62(3), 339\u2013347. doi: 10.1136\/gutjnl-2012-303108 .","journal-title":"Gut"},{"issue":"11","key":"9661_CR59","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1016\/S1470-2045(16)30530-7","volume":"17","author":"WH Raskind","year":"2016","unstructured":"Raskind, W. H., Hisama, F. M., & Bennett, R. L. (2016). Biochemical and imaging surveillance in Li-Fraumeni syndrome. The Lancet Oncology, 17(11), e472. doi: 10.1016\/S1470-2045(16)30530-7 .","journal-title":"The Lancet Oncology"},{"issue":"6","key":"9661_CR60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/PPO.0b013e318278c4a6","volume":"18","author":"S Solomon","year":"2012","unstructured":"Solomon, S., Das, S., Brand, R., & Whitcomb, D. C. (2012). Inherited pancreatic cancer syndromes. The Cancer Journal, 18(6), 485\u2013491. doi: 10.1097\/PPO.0b013e318278c4a6 .","journal-title":"The Cancer Journal"},{"issue":"43","key":"9661_CR61","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1038\/sj.onc.1209873","volume":"25","author":"M Ahmed","year":"2006","unstructured":"Ahmed, M., & Rahman, N. (2006). ATM and breast cancer susceptibility. Oncogene, 25(43), 5906\u20135911. doi: 10.1038\/sj.onc.1209873 .","journal-title":"Oncogene"},{"issue":"5","key":"9661_CR62","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1086\/386293","volume":"74","author":"L Lammi","year":"2004","unstructured":"Lammi, L., Arte, S., Somer, M., J\u00e4rvinen, H., Lahermo, P., Thesleff, I., et al. (2004). Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. The American Journal of Human Genetics, 74(5), 1043\u20131050. doi: 10.1086\/386293 .","journal-title":"The American Journal of Human Genetics"},{"issue":"1","key":"9661_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10549-011-1403-8","volume":"131","author":"M Ratajska","year":"2012","unstructured":"Ratajska, M., Antoszewska, E., Piskorz, A., Brozek, I., Borg, \u00c5., Kusmierek, H., et al. (2012). Cancer predisposing BARD1 mutations in breast\u2013ovarian cancer families. Breast Cancer Research and Treatment, 131(1), 89\u201397. doi: 10.1007\/s10549-011-1403-8 .","journal-title":"Breast Cancer Research and Treatment"},{"key":"9661_CR64","series-title":"GeneReviews(\u00ae)","volume-title":"Juvenile polyposis syndrome","author":"J Larsen Haidle","year":"1993","unstructured":"Larsen Haidle, J., & Howe, J. R. (1993). Juvenile polyposis syndrome, GeneReviews(\u00ae). Seattle: University of Washington."},{"issue":"10","key":"9661_CR65","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall, M. J., Reid, J. E., Burbidge, L. A., Pruss, D., Deffenbaugh, A. M., Frye, C., et al. (2009). BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer, 115(10), 2222\u20132233. doi: 10.1002\/cncr.24200 .","journal-title":"Cancer"},{"key":"9661_CR66","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.055","author":"A Liede","year":"2004","unstructured":"Liede, A., Karlan, B. Y., & Narod, S. A. (2004). Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. Journal of Clinical Oncology. doi: 10.1200\/JCO.2004.05.055 .","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"9661_CR67","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.955","volume":"43","author":"T Rafnar","year":"2011","unstructured":"Rafnar, T., Gudbjartsson, D. F., Sulem, P., Jonasdottir, A., Sigurdsson, A., Jonasdottir, A., et al. (2011). Mutations in BRIP1 confer high risk of ovarian cancer. Nature Genetics, 43(11), 1104\u20131107. doi: 10.1038\/ng.955 .","journal-title":"Nature Genetics"},{"issue":"1","key":"9661_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford, S., Kaurah, P., Li-Chang, H., Woo, M., Senz, J., Pinheiro, H., et al. (2015). Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncology, 1(1), 23\u201332. doi: 10.1001\/jamaoncol.2014.168 .","journal-title":"JAMA Oncology"},{"issue":"6","key":"9661_CR69","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","volume":"52","author":"RS Post van der","year":"2015","unstructured":"van der Post, R. S., Vogelaar, I. P., Carneiro, F., Guilford, P., Huntsman, D., Hoogerbrugge, N., et al. (2015). Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. Journal of Medical Genetics, 52(6), 361\u2013374. doi: 10.1136\/jmedgenet-2015-103094 .","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"9661_CR70","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","volume":"26","author":"M Weischer","year":"2008","unstructured":"Weischer, M., Bojesen, S. E., Ellervik, C., Tybj\u00e6rg-Hansen, A., & Nordestgaard, B. G. (2008). CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. Journal of Clinical Oncology, 26(4), 542\u2013548. doi: 10.1200\/JCO.2007.12.5922 .","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"9661_CR71","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/jmg.2006.044974","volume":"43","author":"C Cybulski","year":"2006","unstructured":"Cybulski, C., Woko\u0142orczyk, D., Huzarski, T., Byrski, T., Gronwald, J., G\u00f3rski, B., et al. (2006). A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. Journal of Medical Genetics, 43(11), 863\u2013866. doi: 10.1136\/jmg.2006.044974 .","journal-title":"Journal of Medical Genetics"},{"issue":"17","key":"9661_CR72","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.ejca.2011.03.025","volume":"47","author":"H Xiang","year":"2011","unstructured":"Xiang, H., Geng, X., Ge, W., & Li, H. (2011). Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility. European Journal of Cancer, 47(17), 2546\u20132551. doi: 10.1016\/j.ejca.2011.03.025 .","journal-title":"European Journal of Cancer"},{"issue":"2","key":"9661_CR73","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ygyno.2011.03.024","volume":"122","author":"KAP Schultz","year":"2011","unstructured":"Schultz, K. A. P., Pacheco, M. C., Yang, J., Williams, G. M., Messinger, Y., Hill, D. A., et al. (2011). Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the international pleuropulmonary blastoma registry. Gynecologic Oncology, 122(2), 246\u2013250. doi: 10.1016\/j.ygyno.2011.03.024 .","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"9661_CR74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1470-2045(10)70265-5","volume":"12","author":"MJ Kempers","year":"2011","unstructured":"Kempers, M. J., Kuiper, R. P., Ockeloen, C. W., Chappuis, P. O., Hutter, P., Rahner, N., et al. (2011). High colorectal and low endometrial cancer risk in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncology, 12(1), 49\u201355. doi: 10.1016\/S1470-2045(10)70265-5 .","journal-title":"Lancet Oncology"},{"key":"9661_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6033-7_5","author":"N Bellam","year":"2010","unstructured":"Bellam, N., & Pasche, B. (2010). Tgf-beta signaling alterations and colon cancer. Cancer treatment and research. doi: 10.1007\/978-1-4419-6033-7_5 .","journal-title":"Cancer treatment and research."},{"key":"9661_CR76","doi-asserted-by":"publisher","unstructured":"Cai, Q., Wang, X., Li, X., Gong, R., Guo, X., Tang, Y., et al. (2015). Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates. Oncotarget, 5(39). doi: 10.18632\/oncotarget.5994 .","DOI":"10.18632\/oncotarget.5994"},{"issue":"12","key":"9661_CR77","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/GIM.0b013e3181be5c97","volume":"11","author":"A Falchetti","year":"2009","unstructured":"Falchetti, A., Marini, F., Luzi, E., Giusti, F., Cavalli, L., Cavalli, T., & Brandi, M. L. (2009). Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genetics in medicine : official journal of the American College of Medical Genetics, 11(12), 825\u2013835. doi: 10.1097\/GIM.0b013e3181be5c97 .","journal-title":"Genetics in medicine : official journal of the American College of Medical Genetics"},{"issue":"1","key":"9661_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12894-016-0130-1","volume":"16","author":"M Dominguez-Valentin","year":"2016","unstructured":"Dominguez-Valentin, M., Joost, P., Therkildsen, C., Jonsson, M., Rambech, E., & Nilbert, M. (2016). Frequent mismatch-repair defects link prostate cancer to Lynch syndrome. BMC Urology, 16(1), 15. doi: 10.1186\/s12894-016-0130-1 .","journal-title":"BMC Urology"},{"key":"9661_CR79","series-title":"GeneReviews(\u00ae)","volume-title":"Lynch syndrome","author":"W Kohlmann","year":"1993","unstructured":"Kohlmann, W., & Gruber, S. B. (1993). Lynch syndrome, GeneReviews(\u00ae). Seattle: University of Washington."},{"issue":"22","key":"9661_CR80","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona, V., Bonaiti, B., Grandjouan, S., Huiart, L., Caron, O., Colas, C., & Bona\u0131, C. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. The Journal of the American Medical Association, 305(22), 2304\u20132310. doi: 10.1001\/jama.2011.743 .","journal-title":"The Journal of the American Medical Association"},{"key":"9661_CR81","doi-asserted-by":"crossref","unstructured":"Win, A. K., Dowty, J. G., Cleary, S. P., Kim, H., Buchanan, D. D., Young, J. P., \u2026 Jenkins, M. A. (2014). Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family HISTORY of cancer. Gastroenterology.","DOI":"10.1053\/j.gastro.2014.01.022"},{"issue":"5","key":"9661_CR82","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1470-2045(11)70076-6","volume":"12","author":"B Zhang","year":"2011","unstructured":"Zhang, B., Beeghly-Fadiel, A., Long, J., & Zheng, W. (2011). Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. The Lancet Oncology, 12(5), 477\u2013488. doi: 10.1016\/S1470-2045(11)70076-6 .","journal-title":"The Lancet Oncology"},{"issue":"4","key":"9661_CR83","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/0008-5472.CAN-03-2502","volume":"64","author":"C Cybulski","year":"2004","unstructured":"Cybulski, C., Gorski, B., Debniak, T., Gliniewicz, B., Mierzejewski, M., Masojc, B., et al. (2004). NBS1 is a prostate cancer susceptibility gene. Cancer Research, 64(4), 1215\u20131219.","journal-title":"Cancer Research"},{"issue":"3","key":"9661_CR84","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10549-016-4003-9","volume":"160","author":"R Graffeo","year":"2016","unstructured":"Graffeo, R., Livraghi, L., Pagani, O., Goldhirsch, A., Partridge, A. H., & Garber, J. E. (2016). Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Research and Treatment, 160(3), 393\u2013410. doi: 10.1007\/s10549-016-4003-9 .","journal-title":"Breast Cancer Research and Treatment"},{"key":"9661_CR85","doi-asserted-by":"publisher","unstructured":"Kanchi, K.L., Johnson, K.J., Lu, C., McLellan, M.D., Leiserson, M.D.M., Wendl, M.C., \u2026 Ding, L. (2014). Integrated analysis of germline and somatic variants in ovarian cancer. Nature Communications, 5. doi: 10.1038\/ncomms4156","DOI":"10.1038\/ncomms4156"},{"issue":"6","key":"9661_CR86","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylk\u00e4s, K., Roberts, J., et al. (2014). Breast-cancer risk in families with mutations in PALB2. The New England Journal of Medicine, 371(6), 497\u2013506. doi: 10.1056\/NEJMoa1400382 .","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"9661_CR87","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/gim.2015.75","volume":"18","author":"F Bellido","year":"2016","unstructured":"Bellido, F., Pineda, M., Aiza, G., Vald\u00e9s-Mas, R., Navarro, M., Puente, D. A., et al. (2016). POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and\/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genetics in Medicine, 18(4), 325\u2013332. doi: 10.1038\/gim.2015.75 .","journal-title":"Genetics in Medicine"},{"issue":"3","key":"9661_CR88","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/bcr3669","volume":"16","author":"F Damiola","year":"2014","unstructured":"Damiola, F., Pertesi, M., Oliver, J., Le Calvez-Kelm, F., Voegele, C., Young, E. L., et al. (2014). Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study. Breast Cancer Research, 16(3), R58. doi: 10.1186\/bcr3669 .","journal-title":"Breast Cancer Research"},{"issue":"1","key":"9661_CR89","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","volume":"137","author":"LE Minion","year":"2015","unstructured":"Minion, L. E., Dolinsky, J. S., Chase, D. M., Dunlop, C. L., Chao, E. C., & Monk, B. J. (2015). Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2. Gynecologic Oncology, 137(1), 86\u201392. doi: 10.1016\/j.ygyno.2015.01.537 .","journal-title":"Gynecologic Oncology"},{"issue":"5","key":"9661_CR90","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/ng.2224","volume":"44","author":"C Loveday","year":"2012","unstructured":"Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., et al. (2012). Germline RAD51C mutations confer susceptibility to ovarian cancer. Nature Genetics, 44(5), 475\u2013476. doi: 10.1038\/ng.2224 .","journal-title":"Nature Genetics"},{"issue":"1","key":"9661_CR91","doi-asserted-by":"publisher","first-page":"e54772","DOI":"10.1371\/journal.pone.0054772","volume":"8","author":"ER Thompson","year":"2013","unstructured":"Thompson, E. R., Rowley, S. M., Sawyer, S., kConFab, Eccles, D. M., Trainer, A. H., et al. (2013). Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer. PloS One, 8(1), e54772. doi: 10.1371\/journal.pone.0054772 .","journal-title":"PloS One"},{"issue":"3","key":"9661_CR92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.4362","volume":"233","author":"WD Foulkes","year":"2014","unstructured":"Foulkes, W. D., Clarke, B. A., Hasselblatt, M., Majewski, J., Albrecht, S., & McCluggage, W. G. (2014). No small surprise\u2014small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour. The Journal of Pathology, 233(3), 209\u2013214. doi: 10.1002\/path.4362 .","journal-title":"The Journal of Pathology"},{"issue":"6","key":"9661_CR93","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/ajg.2009.725","volume":"105","author":"MGF Lier van","year":"2010","unstructured":"van Lier, M. G. F., Wagner, A., Mathus-Vliegen, E. M. H., Kuipers, E. J., Steyerberg, E. W., & van Leerdam, M. E. (2010). High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. The American Journal of Gastroenterology, 105(6), 1258\u20131264 author reply 1265. doi: 10.1038\/ajg.2009.725 .","journal-title":"The American Journal of Gastroenterology"},{"issue":"20","key":"9661_CR94","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier, M., Goldgar, D. E., Sodha, N., Ohgaki, H., Kleihues, P., Hainaut, P., & Eeles, R. A. (2003). Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Research, 63(20), 6643\u20136650.","journal-title":"Cancer Research"},{"issue":"21","key":"9661_CR95","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard, G., Renaux-Petel, M., Flaman, J.-M., Charbonnier, C., Fermey, P., Belotti, M., et al. (2015). Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. Journal of Clinical Oncology, 33(21), 2345\u20132352. doi: 10.1200\/JCO.2014.59.5728 .","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"9661_CR96","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/PAS.0b013e31823d0560","volume":"36","author":"NC Arva","year":"2012","unstructured":"Arva, N. C., Pappas, J. G., Bhatla, T., Raetz, E. A., Macari, M., Ginsburg, H. B., & Hajdu, C. H. (2012). Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis\u2014case report and review of the literature. The American Journal of Surgical Pathology, 36(1), 149\u2013153. doi: 10.1097\/PAS.0b013e31823d0560 .","journal-title":"The American Journal of Surgical Pathology"},{"issue":"9","key":"9661_CR97","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrclinonc.2016.37","volume":"13","author":"XM Keutgen","year":"2016","unstructured":"Keutgen, X. M., Hammel, P., Choyke, P. L., Libutti, S. K., Jonasch, E., & Kebebew, E. (2016). Evaluation and management of pancreatic lesions in patients with von Hippel\u2013Lindau disease. Nature Reviews Clinical Oncology, 13(9), 537\u2013549. doi: 10.1038\/nrclinonc.2016.37 .","journal-title":"Nature Reviews Clinical Oncology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-017-9661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-017-9661-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-017-9661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T11:16:32Z","timestamp":1568891792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-017-9661-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9661"],"URL":"https:\/\/doi.org\/10.1007\/s10555-017-9661-5","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}